Skip to content
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Shopping cart$0.00 0
Login
  • Home
  • About Us
  • Shop
    • Chinese innovative drug
    • Tablets
    • Capsules
    • Injection
    • oral solution
    • Cream/Gel/Ointment
    • ophthalmic preparations
    • Nasal preparations
    • Inhalation preparation
    • Implant
    • Chinese Medicine
  • Blog
  • Contact Us
Xpharma China
Amelie (Almonertinib Mesilate Tablets)
  • Drug news

How much does Amelie (Almonertinib Mesilate Tablets) Cost& price without insurance in China?

Zadaxin (Thymalfasin for Injection)
  • Drug news

How much does Zadaxin (Thymalfasin for Injection) Cost& price without insurance in China?

  • Approved News

Eli Lilly:Sonefpeglutide has been granted exclusive worldwide rights (excluding South Korea) for development, manufacturing, and commercialization.

everest medicines
  • Approved News

Everest Medicines: Civorebrutinib granted exclusive development and commercialization rights in all markets outside Greater China and certain countries in Southeast Asia.

Yunnan Baiyao
  • Approved News

Yunnan Baiyao: INB301 Receives FDA Clearance for Clinical Trials in the U.S.

Vfend (Voriconazole Tablets)
  • Drug news

How much does Vfend (Voriconazole Tablets) Cost& price without insurance in China?

Folotyn (Pralatrexate Injection)
  • Drug news

How much does Folotyn (Pralatrexate Injection) Cost& price without insurance in China?

Dizal
  • Approved News

Dizal: ZEGFROVY®Sunvozertinib, developed by Dizal Pharmaceutical, is poised to reshape the global first-line treatment landscape for EGFR exon20ins NSCLC with its pivotal Phase III study.

Sifrol (Pramipexole Dihydrochloride Sustained-Release Tablets)
  • Drug news

How much does Sifrol (Pramipexole Dihydrochloride Sustained-Release Tablets) Cost& price without insurance in China?

  • Approved News

Akeso: Ivonescimab + Chemotherapy Beats PD-1 + Chemotherapy, OS Significantly Positive

bristol-myers-squibb
  • Approved News

Bristol Myers Squibb: Camzyos mavacamten supplemental New Drug Application (sNDA) accepted by the U.S. FDA.

Amgen
  • Approved News

Amgen:IMDELLTRA®Tarlatamabwas approved in the European Union.

Prev
1 … 7 8 9 10 11 12 13 … 22
Next
Contact us

WeChat: +86 139 2425 9988
WhatsApp : +852 9100 6363
Email: info@xpharma.com.cn

Rm F2-48, 6/F, No. 47 Guomao Road, Hainan, China

Useful Links
  • Medicines
  • Chinese innovative drug
  • Medicines Approved News
  • Drug Development News
  • Drug News
  • Privacy Policy
Email Newsletter

Subscribe to our newsletter and get 10% off your first purchase

Copyright © {2026} -Xpharma China